CHARACTERISTICS OF COMORBIDITY IN HIV INFECTION (on the example of Osh region)
DOI:
https://doi.org/10.54890/.v4i4.1049Abstract
The structure of comorbidities in HIV infection is presented and the Charlson comorbidity index is assessed. A retrospective observational study was performed on the basis of the Infectious diseases department of the Osh interregional united clinical hospital (OIRUCH), the data of 130 patients with HIV infection for the period 2009–2021 were studied. Comorbidity in HIV infection occurs with a high frequency (76.9±3.7%), and in PWID it exceeds for 1.5 times. 26.2% of patients had a high Charlson comorbidity index (7–10 points), indicating a high probability of death within a year. The structure of comorbidity is dominated by infections of the skin and mucous membranes (55.4%), respiratory diseases (53.1%), liver damage (43.1%), AIDS-associated diseases (30.7%). Comorbidity becomes widespread in persons with HIV infection, especially among older patients. This indicates the need for special attention on the part of health workers, additional examinations to identify and treat comorbidity. The results of our study will help raise the awareness of healthcare professionals about the possible complex combinations of comorbidities among HIV- infected people.
Keywords:
HIV infection, comorbidity, PWID, diagnosis, treatmentReferences
1. Хоффман К., Рокштро Ю.К. Лечение ВИЧ-инфекции 2009. М.: Р.Валент; 2010. 648с.
2. Беляков Н.А., Рахманова А.Г., ред. Вирус иммунодефицита человека – медицина. Руководство для врачей. 3-е изд. СПб.: Балтийский медицинский образовательный центр; 2012. 656с.
3. Всемирная организация здравоохранения. Сводное руководство по использованию антиретровирусных препаратов для лечения и профилактики ВИЧ-инфекции: рекомендации с позиций общественного здравоохранения. 2-е изд. Женева:ВОЗ; 2016. 429с. Режим доступа: https://iris.who.int/handle/10665/343998
4. Roomaney RA, van Wyk B, Pillay-van Wyk V. Aging with HIV: Increased Risk of HIV Comorbidities in Older Adults. Int J Environ Res Public Health. 2022 Feb;19(4):2359. https://doi.org/10.3390/ijerph19042359
5. Cahill S, Valadéz R. Growing older with HIV/AIDS: new public health challenges. Am J Public Health. 2013 Mar;103(3):e7-e15. https://doi.org/10.2105/AJPH.2012.301161
6. Guaraldi G, Prakash M, Moecklinghoff C, Stellbrink HJ. Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. AIDS Rev. 2014 Apr-Jun; 16(2):75-89. PMID: 24759453
7. Wing EJ. The aging population with HIV infection. Trans Am Clin Climatol Assoc. 2017;128:131-144. PMC5525433
8. Schouten J, Wit FW, Stolte IG, Kootstra NA, Valk M, Geerlings SE et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014 Dec; 59(12):1787–97. https://doi.org/10.1093/cid/ciu701
9. Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011 Dec;53(11):1120–6. https://doi.org/10.1093/cid/cir627
10. Олейник А.Ф., Фазылов В.Х. Значение коморбидности при ВИЧ-инфекции. Журнал для непрерывного медицинского образования врачей. Инфекционные болезни: новости, мнения, обучение. 2017;(1):101-108.
11. Беляков Н.А., Рассохин В.В., Леонова О.Н. Степанова Е.В., Бобрешова А.С. Интегральная оценка тяжести состояния больного на фоне коморбидности при ВИЧ-инфекции. ВИЧ-инфекция и иммуносупрессия. 2017;9(3):47-53. http://dx.doi.org/10.22328/2077-9828-2017-9-3-47-53
12. Guaraldi G, Zona S, Brothers TD, Carli F, Stentarelli C, Dolci G et al. Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles. PLoS One. 2015 Apr;10(4):e0118531. https://doi.org/10.1371/journal.pone.0118531
13. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age standardization of rates: a new WHO standard EIP/GPE/EBD. World Health Organization. 2001;31:12. Available from: https://cdn.who.int/media/docs/default-source/gho-documents/global-health estimates/gpe_ discussion_ paper_ series_ paper31_2001_age_ standardization_ rates.pdf
14. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva: WHO; 2007. 48 p. Available from: https://iris.who.int/handle/10665/43699
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40(5):373-83. https://doi.org/10.1016/0021-9681(87)90171-8
16. Беляков Н.А., Рассохин В.В. Коморбидные состояния при ВИЧ-инфекции. Основы проблемы. СПб: Балтийский медицинский образовательный центр; 2018. 184c.
17. Урунова Д.М., Ахмеджанова З.И. Оценка индекса коморбидности у ВИЧ-инфицированных пациентов до начала АРТ. Журнал инфектологии. 2022;14(4):94-101. https://doi.org/10.22625/2072-6732-2022-14-4-94-101
18. Gallant J, Hsue P.Y, Shreay S, Meyer N. Comorbidities Among US Patients With Prevalent HIV Infection–A Trend Analysis. J Infect Dis. 2017 Dec; 216(12):1525-1533. https://doi.org/10.1093/infdis/jix518
19. Winston A, Francesco DD, Post F, Boffito M, Vera J, Williams I et al. Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes. AIDS. 2020 Oct;34(12):1795–1800. https://doi.org/10.1097/QAD.0000000000002606
20. Nlooto M. Comorbidities of HIV infection and health care seeking behavior among HIV infected patients attending public sector healthcare facilities in KwaZulu-Natal: A cross sectional study. PLoS One. 2017;12(2):e0170983. https://doi.org/10.1371/journal.pone.0170983
Downloads
Published
How to Cite
Issue
Section
